The more people who are infected with the novel (new) coronavirus that causes COVID-19, the more we’re learning about its effects in the body. Mounting evidence is showing that the virus, called SARS-CoV-2, is neurotropic, or capable of infecting nerve cells.

And while no one has suggested that such infections are more likely to occur in people who already have disease affecting their brains — such as multiple sclerosis (MS) — it’s hard for those of us already living with neurological conditions not to be anxious about the possible consequences such a viral invasion could have.

Reports of Neurologic Symptoms From China

As early as February 2020, the first reports out of Wuhan, China, where the first cases of what came to be known as COVID-19 were reported in December 2019, stated that “Compared with non-severe patients with COVID-19, severe patients commonly had neurologic symptoms manifested as acute cerebrovascular diseases, consciousness impairment, and skeletal muscle symptoms.”

Another study by Asian researchers, published in February, raises the question (but reached no conclusion) as to whether “potential [neuro]invasion of SARS-CoV-2 is partially responsible for the acute respiratory failure of patients with COVID-19.”

A Case of Encephalopathy Reported in Michigan

By the end of March, physicians from the Henry Ford Health System in Detroit reported in the journal Radiology the first case of COVID-19-associated acute necrotizing hemorrhagic encephalopathy, a rare central nervous system complication secondary to influenza or other viral infections that is characterized by altered mental status and seizures. It often leads to profound disability or death.

There are further reported cases of neurologic involvement by SARS-CoV-2, some of which appear to show receptors for the virus not only in the respiratory and digestive tracts but also in the blood-brain barrier and central nervous system nerve endings.
To read this article in its entirity click the link:What Is COVID-19 Doing to the Brain?